Table 2.

Clinicopathologic features of PCAT6 in multiple human cancers.

Tumor Types	Clinicopathologic Features	Ref.
Bladder cancer	Larger tumor size, high tumor differentiation, advanced TNM stage, more lymph nodes metastasis, more distant metastasis	[24]
	Pathological stage	[21]
Breast cancer	More tissues metastasis, higher tumor stages	[26]
	More lymph nodes metastasis, advanced tumor stages	[27]
Cervical cancer	Advanced FIGO stage, more lymph nodes metastasis, depth of cervical invasion	[28]
Colorectal cancer	Tumor subtype, N classification, metastasis, poorer clinical stage	[30]
	Larger tumor size, advanced TNM stage, lymph node metastasis	[31]
Gastric cancer	Larger tumor size, advanced TNM stage, more metastasis	[34]
Hepatocellular carcinoma	Moderated or poorly differentiation, advanced TNM stage	[37]
Lung cancer	Advanced TNM stage, more metastasis	[41]
	Advanced TNM stage, more metastasis	[39]
	Larger tumor size, more lymph node metastasis, advanced TNM stage	[40]
	Larger tumor size, more lymph node metastasis, advanced TNM stage	[20]
	Larger tumor size, more metastasis, advanced TNM stage	[43]
Osteosarcoma	Larger tumor size, more metastasis, advanced TNM stage	[44]
	Larger tumor size, more metastasis, advanced TNM stage	[45]
Ovarian cancer	More lymph node metastasis, more distant metastasis	[47]
	Advanced TNM stage	[48]
Cholangiocarcinoma	Advanced TNM stage	[49]
Pancreatic ductal adenocarcinoma	Advanced TNM stage, more lymph node invasion	[51]
Prostate cancer	Poor differentiation, higher serum PSA, advanced gleason grade, more BM	[53]

TNM, tumor node metastasis; FIGO, Federation of Gynecology and Obstetrics; PSA, prostate specific antigen; BM, bone metastasis.